×

What are you searching for?




Healthcare

4 Min read

$43M raised by Clover Biopharmaceuticals in Series B Funding

Published On 05 Dec 2019 10:43 AM


SHARE THIS ARTICLE  


Based in China, the global clinical-stage bio-tech company Clover Biopharmaceuticalsis focusing on innovative biologic therapies, sealed a US$ 43m (RMB 304m) Series B financing.

Lead by Delos Capital and Lapam Capital, along with some help by from Betta Capital, Sichuan Health Care Industry Fund, Beijing Zhongguancun VC and Jinlong Group, brought the combined capital rise to more than $100 million since 2016.

Continued clin....


Tags : Biopharmaceuticals, Series B Funding , $43M raised, clinical-stage,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)